101155-08-2Relevant articles and documents
Synthesis and anticonvulsant activity of novel purine derivatives
Wang, Shi-Ben,Jin, Peng,Li, Fu-Nan,Quan, Zhe-Shan
, p. 574 - 583 (2014)
A series of new purines containing triazole and other heterocycle substituents was synthesized and evaluated for their preliminary anticonvulsant activity and neurotoxicity by using the maximal electroshock (MES), subcutaneous pentylenetetrazole (scPTZ) and rotarod neurotoxicity (TOX) tests. Among the compounds studied, 9-decyl-6-(1H-1,2,4-triazol-1-yl)-9H-purine (5e) was the most potent compound, with a median effective dose of 23.4 mg/kg and a high protective index of more than 25.6 after intraperitoneal administration in mice. Compound 5e showed significant oral activity against MESinduced seizures in mice, with an ED50 of 39.4 mg/kg and a PI above 31.6. These results demonstrate that compound 5e possesses better anticonvulsant activity and is safer than the commercially available drugs carbamazepine and valproate in MES, scPTZ and TOX models.
9-Benzyladenines: Potent and selective cAMP phosphodiesterase inhibitors [2]
Bourguignon,Desaubry,Raboisson,Wermuth,Lugnier
, p. 1768 - 1770 (2007/10/03)
-
9-(2-fluorobenzyl)-6-(methylamino)9H-purine hydrochloride. Synthesis and anticonvulsant activity
Kelley,Soroko
, p. 1133 - 1134 (2007/10/02)
-
